title: Primary Breast Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma Transformation to Diffuse Large B-cell Lymphoma: A Case Report.
abstract: Primary non-Hodgkin's lymphoma (NHL) of the breast constitutes 0.04%-0.53% of all malignancies and 2.2% of extra nodal lymphomas. In total, 7%-8% of all B-cell lymphomas are the mucosa-associated lymphoid tissue (MALT) type, of which up to 50% of primary gastric MALT lymphoma. Herein we present a patient with breast MALT lymphoma that transformed to diffuse large B-cell lymphoma (DLBCL). A 69-year-old female presented with a mass on her left breast. Physical examination showed a 3×3-cm mass located 1 cm from the areola on the upper lateral quadrant of the breast at the 1 o'clock position, which was fixed and firm. Excisional biopsy was performed and pathologic examination of the specimen showed MALT lymphoma transformation to DLBCL. The patient was staged as II-EA. The rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP) protocol was scheduled as treatment. Following 6 courses of R-CHOP, 2 additional courses of rituximab were administered. Positron emission tomography (PET)-CT was done at the end of the treatment. PET showed that the patient was in complete remission. At the time this report was written, the patient was being followed-up at the outpatient clinic on a regular basis. Lymphoma of the breast is a rarity among malignant tumors of the breast. The most common type of lymphoma is DLBCL. Breast MALT lymphoma is extremely rare. Primary MALT lymphoma of the breast can transform from low grade to high grade and recurrence is possible; therefore, such patients should be monitored carefully for transformation.
authors.affiliation: Dr. Abdurrahman Yurtarslan Oncology Education and Research Hospital, Department of Hematology, Ankara, Turkey.
authors.forename: Serife Hülya
authors.initials: SH
authors.lastname: Arslan
authors.affiliation: Dr. Abdurrahman Yurtarslan Oncology Education and Research Hospital, Department of Medical Oncology, Ankara, Turkey.
authors.forename: Ummügül
authors.initials: U
authors.lastname: Uyetürk
authors.affiliation: Dr. Abdurrahman Yurtarslan Oncology Education and Research Hospital, Department of Hematology, Ankara, Turkey.
authors.forename: Emre
authors.initials: E
authors.lastname: Tekgündüz
authors.affiliation: Dr. Abdurrahman Yurtarslan Oncology Education and Research Hospital, Department of Pathology, Ankara, Turkey.
authors.forename: Sultan Çiğdem
authors.initials: SÇ
authors.lastname: Irkkan
authors.affiliation: Dr. Abdurrahman Yurtarslan Oncology Education and Research Hospital, Department of Hematology, Ankara, Turkey.
authors.forename: Meltem Yüksel
authors.initials: MY
authors.lastname: Kurt
authors.affiliation: Dr. Abdurrahman Yurtarslan Oncology Education and Research Hospital, Department of Hematology, Ankara, Turkey.
authors.forename: Itır Şirinoğlu
authors.initials: IŞ
authors.lastname: Demiriz
authors.affiliation: Dr. Abdurrahman Yurtarslan Oncology Education and Research Hospital, Department of Hematology, Ankara, Turkey.
authors.forename: Fevzi
authors.initials: F
authors.lastname: Altuntaş
keywords: Diffuse large B-cell lymphoma; Primary breast mucosa-associated lymphoid tissue (MALT) lymphoma
references.citation: Cancer. 1995 Jan 1;75(1 Suppl):257-69
references.pmid: 8001000
references.citation: Blood. 2005 Nov 1;106(9):3183-90
references.pmid: 16046532
references.citation: Cancer. 1972 Jun;29(6):1705-12
references.pmid: 4555557
references.citation: Cancer Invest. 2003;21(1):68-72
references.pmid: 12643011
references.citation: Am Surg. 1992 Dec;58(12):792-6
references.pmid: 1456611
references.citation: HIV Clin Trials. 2007 May-Jun;8(3):132-44
references.pmid: 17621460
references.citation: Blood. 2000 Feb 1;95(3):802-6
references.pmid: 10648389
references.citation: Semin Oncol. 1999 Jun;26(3):357-64
references.pmid: 10375092
references.citation: Am J Clin Pathol. 1999 Jan;111(1 Suppl 1):S133-43
references.pmid: 9894478
references.citation: Leuk Lymphoma. 2003 Jan;44(1):149-51
references.pmid: 12691156
references.citation: Clin Breast Cancer. 2008 Apr;8(2):187-8
references.pmid: 18621616